Sachin P Mampatta &Amp;Amp; Ruchika Chitravanshi

Stories by Sachin P Mampatta &Amp;Amp; Ruchika Chitravanshi

Govt proposes phase-wise pre-packed insolvency process

Govt proposes phase-wise pre-packed insolvency process

Rediff.com   18 Jan 2021

A draft proposal by the sub-committee of the insolvency law committee has recommended that the corporate debtor (CD) may initiate the prepack since it may prove difficult to implement if creditors are allowed to do so without the willingness of the promoter.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com   16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

Franklin's voting process on six funds draws flak

Franklin's voting process on six funds draws flak

Rediff.com   15 Jan 2021

There was no postal intimation to unitholders who didn't have a registered email address, according to a letter that Midas Touch Investors Association sent to Sebi.

FPI registrations cross 10K for first time

FPI registrations cross 10K for first time

Rediff.com   13 Jan 2021

Equities in India saw record FPI inflows of $16.8 billion in November and December, taking the benchmark indices to new highs.

As Covid cases start declining, more people are returning to workplaces

As Covid cases start declining, more people are returning to workplaces

Rediff.com   8 Jan 2021

More people seemed to be returning to their workplaces towards the end of the year, even as railway and electricity numbers disappointed. Most other indicators held on to their gains.

Pandemic deals major blow to capex, spending down 88%

Pandemic deals major blow to capex, spending down 88%

Rediff.com   5 Jan 2021

While there were Rs 7.01 trillion worth of new assets in December 2019, this fell 88.6 per cent to Rs 80,000 crore for the three months ending December 2020, shows data from project tracker Centre for Monitoring Indian Economy (CMIE), reports Sachin P Mampatta.

Small firms struggled to raise capital in 2020

Small firms struggled to raise capital in 2020

Rediff.com   5 Jan 2021

'SMEs got infected by Covid.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Stocks: 'Returns will be much more modest'

Stocks: 'Returns will be much more modest'

Rediff.com   30 Dec 2020

'Valuations were depressed at 8,000 (Nifty 50 index) levels. It was a free ride to 12,000 levels.' 'What went down had to come up. Now fundamentals have to support further gains.'

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com   29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Indian hedge funds beat their peers in other emerging markets

Indian hedge funds beat their peers in other emerging markets

Rediff.com   28 Dec 2020

The year-to-date returns are 13.33 per cent for Indian funds, compared to 11.66 per cent for emerging market funds overall.

Reliance emerges as biggest wealth creator over last 25 years

Reliance emerges as biggest wealth creator over last 25 years

Rediff.com   23 Dec 2020

Reliance Industries accounted for Rs 6.3 trillion in wealth created since 1995; closest rival was Hindustan Unilever which was at Rs 4.9 trillion.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com   23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com   19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com   16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.

After festive season boost, key economic indicators show declining signs

After festive season boost, key economic indicators show declining signs

Rediff.com   9 Dec 2020

Business Standard tracks pollution levels, goods ferried by the Indian Railways and consumer visits to various categories of places, in addition to power generation and traffic numbers to understand the fast-changing situation on the ground.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Govt to decriminalise provisions of LLP Act

Govt to decriminalise provisions of LLP Act

Rediff.com   23 Nov 2020

One of the changes being proposed is allowing LLPs to issue non-convertible debentures.

Congress spent Rs 61 lakh on Facebook ads for Bihar polls

Congress spent Rs 61 lakh on Facebook ads for Bihar polls

Rediff.com   18 Nov 2020

Pages for the Bharatiya Janata Party's Bihar arm (BJP Bihar), Janata Dal-United, and Chirag Paswan (of the Lok Janshakti Party) saw between Rs 15 lakh and Rs 30 lakh in ad spends.